SCHEMBL6152201

SCHEMBL6152201

COc1ccc(-c2cc(-c3ccc(OC)cc3)c(C(=O)c3ccccc3)[nH]2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER2 P43116 2/20 0.54
HDAC6 Q9UBN7 5/20 0.52
HDAC3 O15379 4/20 0.52
HDAC1 Q13547 4/20 0.52
HDAC2 Q92769 4/20 0.52
HDAC8 Q9BY41 4/20 0.52
ALDH1A1 P00352 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HDAC4 P56524 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPT P10636 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MET P08581 1/20 0.48
KDR P35968 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL689261 0.86 PTGER2 (0.59) PTGER2HDAC6HDAC3HDAC1HDAC2
SCHEMBL690024 0.86 PTGER2 (0.59) PTGER2HDAC6HDAC3HDAC1HDAC2
SCHEMBL6152705 0.85 ALDH1A1 (0.49) PTGER2HDAC3HDAC1HDAC2ALDH1A1
SCHEMBL1312388 0.85 MAPT (0.50) PTGER2HDAC6HDAC3HDAC1HDAC2
SCHEMBL27867877 0.84 PTGER2 (0.57) PTGER2HDAC6HDAC3HDAC1HDAC2
SCHEMBL689403 0.84 PTGER2 (0.60) PTGER2HDAC6HDAC3HDAC1HDAC2
SCHEMBL6152019 0.82 RARB (0.50) TSHRLMNA
SCHEMBL23758526 0.80 GSK3B (0.47) PTGER2HDAC6HDAC3HDAC1HDAC2
SCHEMBL1567586 0.80 PTGER2 (0.53) PTGER2HDAC6HDAC3HDAC1HDAC2
SCHEMBL6153025 0.79 RARB (0.47) PTGER2HDAC6HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253151-B1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES (JP) 2005-01-12 EP disclosed
US-6805978-B2 COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND TORAY INDUSTRIES, INC. (JP) 2004-10-19 US disclosed
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound TORAY INDUSTRIES, INC. (JP) 2003-05-01 US disclosed
EP-1253151-A1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES, INC. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound PPOX, CPNE4, TP53RK PTGER2 1723/4885HDAC6 4141/4885HDAC3 2414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.